Concepedia

Publication | Open Access

Phase II Study of Erlotinib (OSI-774) in Patients With Advanced Hepatocellular Cancer

DOIFull Paper Access

456

Citations

22

References

2005

Year

Philip A. Philip, Michelle R. Mahoney, Cristine Allmer, James P. Thomas, Henry C. Pitot, George Kim, Ross C. Donehower, Tom R. Fitch, Joel Picus, Charles Erlichman
Journal of Clinical Oncology

Abstract

Results of this trial suggest a benefit for EGFR/HER1 blockade with erlotinib in patients with HCC manifested by disease control. Additional studies with erlotinib as a single agent or in combination with other agents are warranted.

References

YearCitations

Page 1